◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Astellas Pharma Inc. (4503) Financial History

Name: Astellas Pharma Inc. (4503) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Astellas Pharma Inc. (4503) operates in the Drug Manufacturers - General industry and is headquartered in Chuo, Japan with about 14,099 employees. Its market capitalization is roughly JPY 4.24 trillion. In the fiscal year ended 2026-03-31, 4503 reported JPY 2.14T in revenue and JPY 291.5B in net income.

Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Interactive charts & full statements →

4503 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 2.14T	JPY 1.91T	JPY 1.60T	JPY 1.52T
Gross Profit	JPY 1.73T	JPY 1.56T	JPY 1.31T	JPY 1.23T
Operating Income (EBIT)	JPY 380.1B	JPY 40.2B	JPY 18.9B	JPY 131.6B
Net Income	JPY 291.5B	JPY 50.7B	JPY 17.0B	JPY 98.7B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4503 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 136.1B)	(JPY 129.0B)	(JPY 116.7B)	(JPY 100.4B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4503 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 3.57T	JPY 3.34T	JPY 3.57T	JPY 2.46T
Total Liabilities	JPY 1.74T	JPY 1.83T	JPY 1.97T	JPY 948.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4503 viewer.

4503 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4519 · Chugai Pharmaceutical Co., Ltd. — $11.70 trillion
4578 · Otsuka Holdings Co., Ltd. — $6.60 trillion
4568 · Daiichi Sankyo Company, Limited — $5.10 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4502 All “0-9” companies 4506 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.